Association of Biotechnology Led Enterprises

News

Nectar Biopharma launches generic diabetes treatment drug in India

The company will also sell the combination drug containing vildagliptin and metformin under the brand name Galvildamet.

Dec 26, 2019

By : Team ABLE

FDA approves first generic version of popular blood thinner drug

The generic apixaban approvals were granted to Micro Labs Limited and Mylan Pharmaceuticals Inc.

Dec 26, 2019

By : Team ABLE

Glenmark Pharma secures product approval for Ryaltris in Australia

Glenmark plans to commercialize Ryaltrisin several markets globally, either on its own or through partnerships.

Dec 23, 2019

By : Team ABLE

iView records first patient treated in Adenoviral Conjunctivitis drug clinical trial

Acute infectious conjunctivitis is a leading cause of ocular morbidity, epidemic eye infection, lost productivity, patient discomfort and in some cases permanent visual compromise.

Dec 23, 2019

By : Team ABLE

NIH pledges up to $102 million to Antibacterial Resistance Leadership Group

The group will investigate vaccines, bacteriophages and microbiomes, and will work on improving diagnostic tests and the appropriate use of existing antibiotics.

Dec 23, 2019

By : Team ABLE